Genomic Profiling of Kidney Ischemia-Reperfusion Reveals Expression of Specific Alloimmunity-Associated Genes: Linking "Immune" and "Nonimmune" Injury Events

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3333-3336

  Grigoryev, D N ^a   Liu, M ^a   Cheadle, C ^a   Barnes, K C ^a   Rabb, H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; GAS CHROMATOGRAPHY; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENOMICS; HISTOCOMPATIBILITY GENE; KIDNEY; KIDNEY ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSPLANTATION; UPREGULATION;

ANIMALS; CREATININE; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C57BL; RENAL CIRCULATION; REPERFUSION; REPERFUSION INJURY; RNA, COMPLEMENTARY;

EID: 33845451573     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.129     Document Type: Article

References (28)

1. Tilney N.L., and Guttmann R.D. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 64 (1997) 945
2. Terasaki P.I., Cecka J.M., Gjertson D.W., et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333 (1995) 333
3. Boros P., and Bromberg J.S. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 6 (2006) 652
4. Waddell T.K., Gorczynski R.M., DeCampos K.N., et al. Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg 62 (1996) 866
5. Penfield J.G., Wang Y., Li S., et al. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Int 56 (1999) 1759
6. Savransky V., Molls R.R., Burne-Taney M., et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int 69 (2006) 233
7. Rabb H. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 61 (2002) 1935
8. Nikbakht-Sangari M., Qayumi A.K., and Keown P.A. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. Immunol Invest 29 (2000) 13
9. Wu H.S., Zhang J.X., Wang L., et al. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 3 (2004) 250
10. Kim B.S., Lim S.W., Li C., et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79 (2005) 1370
11. de Vries B., Walter S.J., Peutz-Kootstra C.J., et al. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 165 (2004) 1677
12. Sacks S.H., and Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant 3 (2003) 927
13. Molls R.R., Savransky V., Liu M., et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 290 (2006) F1187
14. Kaminska D., Tyran B., Mazanowska O., et al. Cytokine gene expression in kidney allograft donor biopsies after cold ischemia and reperfusion using in situ RT-PCR analysis. Transplant Proc 35 (2003) 2155
15. Chen D., Ding Y., Schroppel B., et al. Differential chemokine and chemokine receptor gene induction by ischemia, alloantigen, and gene transfer in cardiac grafts. Am J Transplant 3 (2003) 1216
16. Treska V., Molacek J., Kuntscher V., et al. Immunosuppresive agents have an influence on ischemia-reperfusion injury in kidneys procured from a non-heart-beating donor: experimental study. Transplant Proc 36 (2004) 2931
17. Loverre A., Ditonno P., Crovace A., et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 15 (2004) 2675
18. Yang C.W., Ahn H.J., Han H.J., et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation 72 (2001) 1753
19. Dahlquist K.D., Salomonis N., Vranizan K., et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31 (2002) 19
20. Doniger S.W., Salomonis N., Dahlquist K.D., et al. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4 (2003) R7
21. Becker K.G., Hosack D.A., Dennis Jr. G., et al. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 4 (2003) 61
22. Saeed A.I., Sharov V., White J., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374
23. Kobayashi T., Walsh M.C., and Choi Y. The role of TRAF6 in signal transduction and the immune response. Microbes Infect 6 (2004) 1333
24. Mendez R., Gonwa T., Yang H.C., et al. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation 80 (2005) 303
25. Squadrito F., Altavilla D., Squadrito G., et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury. J Mol Cell Cardiol 32 (2000) 429
26. Lebedeva T., Dustin M.L., and Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol 17 (2005) 251
27. Fong S., Mounkes L., Liu Y., et al. Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family. Proc Natl Acad Sci U S A 100 (2003) 14253
28. Hocherl K., Dreher F., Vitzthum H., et al. Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol 13 (2002) 2427